Kessler Topaz Meltzer & Check, LLP Files Securities Class Action Lawsuit Against Applied Therapeutics, Inc.
Radnor, PA / ACCESS Newswire / January 31, 2025
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024, and December 2, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 18, 2025.
The lawsuit alleges that Applied Therapeutics made false or misleading statements during the Class Period regarding the efficacy and safety of its lead drug candidate, leading to inflated stock prices. On December 3, 2024, news broke that the U.S. Food and Drug Administration had placed a partial clinical hold on the company’s IND application for the drug, causing the stock price to plummet by over 60%.
Investors who suffered losses during the Class Period may be eligible to participate in the lawsuit and seek compensation for damages. If you purchased Applied Therapeutics securities between January 3, 2024, and December 2, 2024, you are encouraged to contact Kessler Topaz Meltzer & Check, LLP to discuss your legal rights.
With the lead plaintiff deadline fast approaching on February 18, 2025, affected investors are urged to act promptly to protect their interests in this securities class action lawsuit against Applied Therapeutics, Inc.
Impact on Individuals:
If you are an investor who purchased Applied Therapeutics securities during the Class Period, this lawsuit could provide an opportunity for you to seek compensation for any losses you incurred as a result of the alleged false or misleading statements made by the company. By participating in the class action, you may be able to recover damages and hold Applied Therapeutics accountable for its actions.
Impact on the World:
Securities class action lawsuits play a crucial role in holding companies accountable for their actions and ensuring transparency and integrity in the financial markets. By filing this lawsuit against Applied Therapeutics, investors are seeking justice and seeking to prevent future misconduct by companies in the pharmaceutical industry. This case could set a precedent for increased scrutiny and accountability within the industry, benefitting investors and the public at large.
Conclusion:
As the legal proceedings unfold in the securities class action lawsuit against Applied Therapeutics, investors should closely monitor developments and consider their options for seeking compensation for any losses they may have suffered. By participating in the lawsuit, affected investors can seek to hold the company accountable for its alleged misconduct and potentially recover damages. Contacting a reputable law firm like Kessler Topaz Meltzer & Check, LLP can help investors navigate the complex legal process and protect their rights in this case.
